HUAHE · Supply, research and development
HUAHE connects global lutetium-177 (Lu-177) and actinium-225 (Ac-225) supply, project-specific lead-212 (Pb-212) supply management and radiopharmaceutical R&D. We work with pharmaceutical and biotechnology companies, universities and research institutions. Our Shanghai and Qinshan teams define scope, responsibilities and stage deliverables, from candidate comparison and process development to technology transfer and manufacturing and supply integration.
HUAHE supplies Lu-177 and Ac-225 globally. For lead-212 (Pb-212), we manage supply for individual projects, including requirements, batch planning, quality documents, logistics and receipt. Availability, specifications, activity at the agreed reference date and time, applicable authorizations and delivery conditions are confirmed for each project and accepted order.
Service details in English
Radiolabeling, analytical characterization, small-animal imaging and biodistribution studies support candidate comparisons, risk identification and planning for the next research stage. Study scope, methods and deliverables are defined for each project; research findings are not evidence of clinical efficacy or product approval.
Service details in EnglishHUAHE connects process and analytical development with technology transfer and manufacturing and supply integration. Licensed manufacturers operate under their own quality systems and retain responsibility for manufacturing, testing and batch release. Site requirements, documentation and each party’s responsibilities are agreed for the project.
Service details in EnglishTheranostics connects diagnostic imaging and targeted treatment in nuclear medicine, often through a common biological target. HUAHE supports radionuclide supply and radiopharmaceutical development projects in this field. We work with professional organizations and do not provide diagnosis, treatment or medical appointments for patients.
Service details in EnglishFor professional business and research collaboration. Services are subject to agreed project scope, site qualifications and applicable requirements. This information does not establish clinical efficacy, product approval or a supply commitment.
